Histopathology and Tissue Shared Resource

HTSR Home | Services & Fees | Educational Resources | Publications | Schedule

Publications

2003 2004 2005 2006 2007 2008 2009 2010 2011

2008

Jones LP, Tilli MT, Assefnia S, Torre K, Halama ED, Parrish A, Rosen EM, and Furth PA. (2008) Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERα negative and ERα positive mammary preneoplasia and cancer. Oncogene 27(6)794-802.

Tilli, MT, Parrish, AR, Cotarla, I, Jones, LP, Johnson, MD and Furth, PA. (2008) Comparison of mouse mammary gland imaging techniques and applications: reflectance confocal microscopy, GFP Imaging, and ultrasound. BMC Cancer 8:21.

Hwang SH, Rait A, Pirollo KF, Zhou Q, Yenugonda VM, Chinigo GM, Brown ML, and Chang EH. (2008) Tumor-Targeting Nanodelivery Enhances the Anticancer Activity of Novel Quinazolinone Analog. Molecular Cancer Therapeutics 7(3) 559-568.

Ji Y, Shah S, Soanes K, Islam MN, Hoxter B, Biffo S, Heslip T, Byers S. (2008) Eukaryotic initiation factor 6 selectively regulates Wnt signaling and beta-catenin protein synthesis. Oncogene 27(6):755-62.

Foshay K, and Gallicano GI. (2008) Regulation of Sox2 by STAT3 initiates commitment to the precursor cell fate. Stem Cells and Development. 17(2):269-278.

Frech MS, Torre KM, Robinson GW, Furth PA. (2008) Loss of cyclin D1 in concert with deregulated estrogen receptor alpha expression induces DNA damage response activation and interrupts mammary gland morphogenesis. Oncogene 27:3186-3193.

Wang X, Yin Y, Yuan H, Sakamaki T, Okano H, and Glazer RI. (2008) Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways. Mol. Cell. Biol. 28(11)3589-3599.

Fishbein T, Novitskiy G, Mishra L, Matsumoto C, Kaufman S, Goyal S, Shetty K, Johnson L, Lu A, Wang A, Fu F, Kallakury B, Lough D, Zasloff M. (2008) NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 557:323-330.

Fereshteh, MP, Tilli, M. T., Kim, S. E., Xu, J., O'Malley, B. W., Wellstein, A., Furth, P. A., and Riegel, A. T. (2008) The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice. Cancer Res 2008;68:3697-3706.

Olivo-Marston, SE, Zhu, Y., Lee, R. Y., Cabanes A, Khan, G., Zwart, A., Wang, Y., Clarke, R., and Hilakivi-Clarke, L. (2008) Gene signaling pathways mediating the opposite effects of prepubertal low-fat and high-fat n-3 polyunsaturated fatty acid diets on mammary cancer risk. Cancer Prev Res 1:532-45.

Wang, M, Yu, B., Westerlind, K., Strange, R., Khan, G., Patil, D., Boeneman, K., and Hilakivi-Clarke, L. (2008). Prepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary gland 2. Breast Cancer Res Treat, May 31 epub.

Calvo A, Catena R, Noble MS, Carbott D, Gil-Bazo I, Gonzalez-Moreno O, Huh JI, Sharp R, Qiu TH, Anver MR, Merlino G, Dickson RB, Johnson MD, Green JE. (2008) Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene 27(40):5373-5384.

Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL. (2008) Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 17(5):1082-1087.

Tan D, Goerlitz DS, Dumitrescu RG, Han D, Seillier-Moiseiwitsch F, Spernak SM, Orden RA, Chen J, Goldman R, Shields PG. (2008) Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells. Carcinogenesis 29(6):1170-1177.